FDA Approvals Roundup: Kloxxado, Farxiga, Ferriprox
The Pharma Data
MAY 5, 2021
A weekly update on new drug approvals and indications from the US Food and Drug Administration (FDA). . New approvals. Hikma’s Kloxxado (naloxone hydrochloride nasal spray) has been approved for treating opioid overdose. Higher-dose Kloxxado nasal spray cleared for countering opioid overdose.
Let's personalize your content